Table 2 Correlation between expression levels of TRAIL variants and clinicopathological parameters
p-value | ||||
|---|---|---|---|---|
Variables | No. of patients | TRAIL-α | TRAIL-β | TRAIL-γ |
Primary site | 0.898 | 0.415 | 0.728 | |
Proximal | 16 | |||
Corpus/Fundus | 13 | |||
Antrum/Pylorus | 12 | |||
Stage (UICC) | 24 | 0.682 | 0.588 | 0.721 |
I + II | 17 | |||
III + IV | ||||
Histological grade a | ||||
G2 | 9 | 0.625 | 0.582 | 0.494 |
G3 | 31 | |||
Histological type | ||||
Intestinal | 17 | 0.089 | 0.272 | 0.231 |
Diffuse | 21 | |||
Mixed | b | |||
Lymphatic vessel invasion | ||||
Positive | 23 | 0.948 | 0.509 | 0.895 |
Negative | 18 | |||
Blood vessel invasion | ||||
Positive | 8 | 0.349 | 0.633 | 0.681 |
Negative | 33 | |||
Helicobacter pylori infection | ||||
Positive | 13 | 0.234 | 0.127 | 0.071 |
Negative | 28 | |||
Sex | ||||
female | 14 | 0.945 | 0.290 | 0.858 |
male | 27 | |||
Age | ||||
< 64 Jahre | 19 | 0.764 | 0.140 | 0.969 |
≥ 64 Jahre | 22 | |||